CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $30,593,000 | +105.8% | 10,772,111 | +107.2% | 0.46% | +107.7% |
| Q3 2017 | $14,865,000 | -29.4% | 5,197,658 | -39.0% | 0.22% | -26.9% |
| Q2 2017 | $21,061,000 | -3.1% | 8,526,619 | +41.6% | 0.30% | -1.3% |
| Q1 2017 | $21,731,000 | -0.9% | 6,019,590 | -2.8% | 0.30% | -1.0% |
| Q4 2016 | $21,933,000 | +86.7% | 6,195,855 | +113.1% | 0.31% | +100.0% |
| Q3 2016 | $11,746,000 | -49.2% | 2,907,523 | -44.7% | 0.15% | -42.5% |
| Q2 2016 | $23,100,000 | +105.3% | 5,261,934 | +76.8% | 0.27% | +121.5% |
| Q1 2016 | $11,251,000 | -80.1% | 2,976,400 | -17.6% | 0.12% | -78.7% |
| Q4 2015 | $56,605,000 | +72.7% | 3,610,008 | +16.1% | 0.57% | +117.2% |
| Q3 2015 | $32,775,000 | -49.9% | 3,109,615 | +20.0% | 0.26% | -37.9% |
| Q2 2015 | $65,363,000 | -16.3% | 2,591,703 | -7.5% | 0.42% | -0.9% |
| Q1 2015 | $78,056,000 | +33.8% | 2,800,700 | -12.4% | 0.42% | +46.7% |
| Q4 2014 | $58,340,000 | +26.0% | 3,196,700 | -10.5% | 0.29% | +35.7% |
| Q3 2014 | $46,288,000 | -20.9% | 3,571,600 | -0.3% | 0.21% | -9.4% |
| Q2 2014 | $58,484,000 | +23.9% | 3,583,600 | +34.1% | 0.24% | +26.3% |
| Q1 2014 | $47,214,000 | +16.7% | 2,672,000 | +59.9% | 0.19% | +20.0% |
| Q4 2013 | $40,455,000 | – | 1,671,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |